The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.

Massachusetts. On Jan. 15, 2025, a warning letter was sent to Sanofi stating that FDA inspectors found irregularities with the facility’s bioreactor, the vessel used to grow organisms and cells.

A fast-casual restaurant that serves Korean and Mexican food has received approval to open on Route 9 in Framingham.

Elshoma McCoy, 49, of 176 Waverly St., Framingham, is charged with illegal possession of a firearm; illegal possession of a ...

The owners of 3 Idlewile Lane in Weston admired a home they saw in Architectural Digest, so they purchased over eight acres ...

Framingham-based retail parent TJX Cos. has purchased two office parcels on Framingham’s Speen Street for $24.3 million.

Thomas Method said he entered the Capitol building but left within 10 minutes because he didn't know it was going to turn ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...

Dogs can also be affected by certain pet food, but the Food and Drug Administration (FDA) has stated that their ... since 2022 - there have been none in Massachusetts," DPH spokesperson Kathleen ...